Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.

NCT03163732 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT03163732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03163732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2017
Completion date
November 23, 2021
Enrollment
341 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor